Predict what? The company clearly outlined in their investor day in December that they would need more funding to get Zilosul to market. They also gave clear reasons why with durability studies, hip OA study etc being invested in.
They also talk about the options available for funding. I'm hopeful for a rights issue but will leave it up to management to decide.
Maybe no-one mentioned it because it is so obvoius. Not sure why you have decided to make a big issue out of it as well as CEO recruitment as they are clearly taking their time to find the right person.
research reports and media, page-2752
-
- There are more pages in this discussion • 1,653 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 22.8¢ | 23.3¢ | 22.5¢ | $40.27K | 174.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 117459 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 151209 | 11 |
View Market Depth
| Last trade - 15.39pm 16/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |